96-20341. Rhone Merieux, Inc.; Withdrawal of Approval of NADA  

  • [Federal Register Volume 61, Number 155 (Friday, August 9, 1996)]
    [Notices]
    [Page 41635]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-20341]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Food and Drug Administration
    [Docket No. 96N-0165]
    
    
    Rhone Merieux, Inc.; Withdrawal of Approval of NADA
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval 
    of a new animal drug application (NADA) held by Rhone Merieux, Inc. The 
    NADA provides for the use of Gallimycin (erythromycin) 
    Poultry Formula in poultry drinking water. The sponsor requested the 
    withdrawal of approval because the animal drug product is no longer 
    manufactured or marketed.
    
    EFFECTIVE DATE: August 19, 1996.
    
    FOR FURTHER INFORMATION CONTACT: Dianne T. McRae, Center for Veterinary 
    Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., 
    Rockville, MD 20855, 301-594-1623.
    
    SUPPLEMENTARY INFORMATION: Rhone Merieux, Inc., P.O. Box 459, 2116 
    Eighth Avenue South, Fort Dodge, IA 50501, is the sponsor of NADA 102-
    656, which provides for the use of Gallimycin (erythromycin) 
    Poultry Formula in poultry drinking water. By letter of April 17, 1996, 
    Rhone Merieux, Inc., requested withdrawal of approval of the NADA 
    because the animal drug product is no longer manufactured or marketed.
        Therefore, under authority delegated to the Commissioner of Food 
    and Drugs (21 CFR 5.10) and redelegated to the Center for Veterinary 
    Medicine (21 CFR 5.84), and in accordance with Sec. 514.115 Withdrawal 
    of approval of applications (21 CFR 514.115), notice is given that 
    approval
    of NADA 102-656 and all supplements and amendments thereto is hereby 
    withdrawn, effective August 19, 1996.
    
        Dated: July 17, 1996.
    Stephen F. Sundlof,
    Director, Center for Veterinary Medicine.
    [FR Doc. 96-20341 Filed 8-8-96; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
8/19/1996
Published:
08/09/1996
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
96-20341
Dates:
August 19, 1996.
Pages:
41635-41635 (1 pages)
Docket Numbers:
Docket No. 96N-0165
PDF File:
96-20341.pdf